Product Categories
Country: | United States |
---|---|
Tel: | 781-+1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
Eflucimibe;F12511;L0081;L-0081;F-12511 | C29H43NO2S | 202340-45-2 | Details |
Disopyramide phosphate;SC-13957;SC13957;SC 13957 | C21H32N3O5P | 22059-60-5 | Details |
Metkephamid acetate;Lilly 127623;LY-127623;LY 127623;LY127623 | C31H44N6O8S | 66960-35-8 | Details |
Pentamidine dihydrochloride;MP-601205 dihydrochloride | C19H26Cl2N4O2 | 50357-45-4 | Details |
TAK-441;TAK441;TAK 441 | C28H31F3N4O6 | 1186231-83-3 | Details |
Imatinib hydrochloride | C29H32ClN7O | 862366-25-4 | Details |
GRN-529;GRN 529;GRN529 | C22H15F2N3O2 | 1253291-12-1 | Details |
NCDM-32B;NCDM32B;NCDM 32B | C15H30N2O4 | 1239468-48-4 | Details |
GSK1104252A;GSK-1104252A;GSK 1104252A | C22H27FN4O5S | 1001397-20-1 | Details |
Varespladib methyl;LY333013;A-002 | C22H22N2O5 | 172733-08-3 | Details |
Hoechst 33342 trihydrochloride;Hoechst 33342;bisBenzimide H 33342 trihydrochloride;HOE 33342 trihydrochloride | C27H29ClN6O | 875756-97-1 | Details |
H2L 5765834 | C21H12N2O7 | 420841-84-5 | Details |
TDP665759;TDP 665759;JNJ-27291199;JNJ27291199;TDP-665759;JNJ 27291199 | C31H34Cl2IN5O2 | 787632-66-0 | Details |
Ragaglitazar;NNC 61-0029;NNC-61-0029;NN 622;NNC61-0029;(-)-DRF-2725;NN-622 | C25H25NO5 | 222834-30-2 | Details |
AZD-1656;AZD 1656;AZD1656 | C24H26N6O5 | 919783-22-5 | Details |
GPR35 agonist 2;TC-G 1001 | C17H11FN2O3S | 494191-73-0 | Details |
S-4048;S 4048;S4048 | C32H30ClN3O7 | 173534-37-7 | Details |
MI-2-2;MI 2 2;MI22 | C17H20F3N5S2 | 1454920-20-7 | Details |
(S)-Warfarin | C19H16O4 | 5543-57-7 | Details |
VUF 5574 | C21H17N5O2 | 280570-45-8 | Details |
NK3201;NK-3201;NK 3201 | C31H29N5O6 | 204460-24-2 | Details |
TP-353;EOS-61973 | C35H30FNO3 | 1253799-29-9 | Details |
Cardionogen 1 | C13H14N4OS | 577696-37-8 | Details |
BI-6015;BI6015 | C15H13N3O4S | 93987-29-2 | Details |
ML368;ML 368;SR 9186;ML-368;SR9186;SR-9186 | C26H18N6O | 1361414-26-7 | Details |
MrgX1-Activator-1 | C14H16ClN3O3S | 793731-95-0 | Details |
MCP110;MCP-110;MCP 110 | C33H36N2O3 | 521310-51-0 | Details |
Azido-PEG23 amine;Amino-PEG23-azide | C24H50N4O11 | 749244-38-0 | Details |
Auglurant;VU0424238 | C16H12FN5O2 | 1396337-04-4 | Details |
BMS-767778;BMS767778;BMS 767778 | C19H20Cl2N4O2 | 915729-95-2 | Details |
Amino-PEG10-acid | C27H65NO14 | 196936-04-6 | Details |
Stilbamidine dihydrochloride;NCI 174;NSC 35605 | C16H18Cl2N4 | 6935-63-3 | Details |
7-Troc-paclitaxel;7 Troc paclitaxel | C50H52Cl3NO16 | 114915-17-2 | Details |
Flufiprole;Butene-fipronil;Rizazole | C16H10Cl2F6N4OS | 704886-18-0 | Details |
SAR-020106 | C19H19ClN6O | 1184843-57-9 | Details |
IAA-94;IAA94;IAA 94 | C17H18Cl2O4 | 53108-00-2 | Details |
Tipifarnib (S enantiomer);IND-58359 S enantiomer;(S)-(-)-R-115777;Tipifarnib S enantiomer;(S)-Tipifarnib | C27H22Cl2N4O | 192185-71-0 | Details |
Finerenone;BAY 948862;BAY-948862;BAY94-8862;BAY948862;BAY-94-8862;BAY 94-8862 | C21H22N4O3 | 1050477-31-0 | Details |
Amino-PEG12-alcohol | C24H51NO12 | 933789-97-0 | Details |
MreB Perturbing Compound A22 hydrochloride;A22 hydrochloride;MreB Perturbing Compound A22 | C8H9Cl3N2S | 22816-60-0 | Details |
Rhodblock 6;Rhodblock6;Rhodblock-6 | C12H13N3O | 886625-06-5 | Details |
NP603;NP-603;NP 603 | C26H26N2O5 | 949164-80-1 | Details |
SPV106 | C22H40O4 | 1036939-38-4 | Details |
YM-298198 hydrochloride;YM 298198 hydrochloride | C18H23ClN4OS | 1216398-09-2 | Details |
EGA | C16H16BrN3O | 415687-81-9 | Details |
CRANAD 2 | C23H25BF2N2O2 | 1193447-34-5 | Details |
JW 67 | C21H18N2O6 | 442644-28-2 | Details |
SR1664;SR 1664 | C33H29N3O5 | 1338259-05-4 | Details |
7DG;7-DG | C26H30O5 | 26927-01-5 | Details |
BFMO (biogenic Fe-Mn oxides);N,N'-Difurfuryloxamide | C12H12N2O4 | 69010-90-8 | Details |
Isomaltitol;Palatinit;Isomalt | C12H24O11 | 534-73-6 | Details |
Fenvalerate;Evercide 2362 | C25H22ClNO3 | 51630-58-1 | Details |
Triethoxyoctylsilane;Oleth-30;Triethoxycaprylylsilane;NSC 42964 | C14H32O3Si | 2943-75-1 | Details |
Aeroplysinin 1;NSC-170364;NSC 170364;Aeroplysinin I;NSC170364 | C9H9Br2NO3 | 28656-91-9 | Details |
Ceftazidime;GR20263 | C22H22N6O7S2 | 72558-82-8 | Details |
DAT1;DAT 1;DAT-1 | C17H15N3O2S | 107401-70-7 | Details |
DCB | C14H10Cl2N2 | 6971-97-7 | Details |
RJR 2429 dihydrochloride | C11H16Cl2N2 | 1021418-53-0 | Details |
LB-205;LB205;LB 205 | C18H21N3O2S | 1113025-86-7 | Details |
Benzylurea;N-Benzylurea;Benzylcarbamide;1-Benzylurea;Phenylmethylurea;AI3-61350 | C8H10N2O | 538-32-9 | Details |
546C88;L-NMMA;NG-Monomethyl-L-arginine hydrochloride;L-N(G)-Methylarginine hydrochloride | C7H16N4O2 | 156706-47-7 | Details |
GSK356278;GSK-356278;GSK 356278 | C21H25N7O2S | 720704-34-7 | Details |
Wee1 Inhibitor II;Wee1-Inhibitor II;Wee1-Inhibitor-II;Wee1 Inhibitor-II | C24H19ClN2O3 | 622855-50-9 | Details |
(±)-CPSI-1306 | C15H16F2N2O3 | 1309793-47-2 | Details |
PTAC oxalate | C14H21N3O4S2 | 201939-40-4 | Details |
TC LPA5 4 | C23H23ClN2O3 | 1393814-38-4 | Details |
TC-I 15 | C23H28N4O6S2 | 916734-43-5 | Details |
Sm4 | C19H16O3 | 365542-77-4 | Details |
NSC 31156;5-[(3,4-dimethoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione | C12H11NO4S | 6325-95-7 | Details |
Lamivudine sulfoxide, (R)-;GI138870X;GI 138870X;Lamivudine impurity H;GI-138870X | C8H11N3O4S | 160552-54-5 | Details |
Hydroxy-PEG3-acid | C9H18O6 | 518044-49-0 | Details |
Azidoethyl-SS-ethylalcohol | C4H9N3OS2 | 1807540-82-4 | Details |
GSK-A1 | C29H27FN6O4S | 1416334-69-4 | Details |
TSI-01;TSI 01;TSI01 | C14H11Cl2NO4 | 704878-75-1 | Details |
Hydrocinchonine;Dihydrocinchonine | C19H24N2O | 485-65-4 | Details |
Todralazine hydrochloride;Ecarazine hydrochloride | C11H13ClN4O2 | 3778-76-5 | Details |
TY-52156 | C18H19Cl2N3O | 934369-14-9 | Details |
ARN14974 | C24H21FN2O3 | 1644158-57-5 | Details |
Sodium methanearsonate;Methylarsonat monosodny;Methylarsenic acid, sodium salt;Monosodium acid metharsonate | CH4AsO3.Na | 2163-80-6 | Details |
Benzyl lactate;AI315720;AI3-15720;AI3 15720 | C10H12O3 | 2051-96-9 | Details |
Iodiconazole | C19H19F2IN4O | 887138-63-8 | Details |
SDM25N hydrochloride | C26H27ClN2O3 | 342884-71-3 | Details |
Hydroquinone diacetate;NSC9277;NSC-9277;NSC 9277 | C10H10O4 | 1205-91-0 | Details |
6-Alkynyl-fucose;6-Alk-Fuc | C7H10O5 | 1193251-61-4 | Details |
RP-72540;RPR-102681;RP 72540;RPR 102681;RP72540;RPR102681 | C28H30N4O6 | 139088-45-2 | Details |
FK960;FK-960;FK-59960;FK 59960;FK59960 | C13H16FN3O2 | 133920-70-4 | Details |
K6PC-5;K6PC 5;K6PC5 | C19H37NO4 | 756875-51-1 | Details |
N106;N 106;N-106 | C17H14N4O3S | 862974-25-2 | Details |
NHI-2;NHI2;NHI 2 | C17H12F3NO3 | 1269802-97-2 | Details |
Product Total: Product Page: | ||||
158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 |